CJC-1295/Ipamorelin

Common questions about CJC-1295/Ipamorelin

What is CJC-1295/Ipamorelin and how do the two peptides work together?

CJC-1295/Ipamorelin is a compounded blend of two growth hormone secretagogues that work through complementary mechanisms. CJC-1295 is a growth hormone-releasing hormone (GHRH) analog with extended half-life that increases the amount of GH the pituitary produces per release event. Ipamorelin is a selective ghrelin receptor agonist that triggers a clean GH pulse without raising cortisol or prolactin. Used together they produce a stronger and more natural pulsatile GH release than either peptide alone. The 10 mg + 10 mg blend vial is $100 with a $39 medical visit fee.

Does CJC-1295/Ipamorelin actually work for growth hormone support?

Yes, multiple clinical studies on each peptide individually show measurable increases in IGF-1 and GH pulse amplitude after 4 to 8 weeks of consistent use. The combined CJC-1295/Ipamorelin protocol is widely used in age-management and sports medicine practices for body composition, sleep quality, and recovery support. Effects build gradually; expected outcomes include improved sleep depth within 2 to 4 weeks, body composition changes (reduced visceral fat, increased lean mass) at 8 to 12 weeks, and skin and recovery improvements through that period.

How much CJC-1295/Ipamorelin should I inject?

The PeptideRx starting dose is 20 units (0.4 mg of each peptide) on a U-100 insulin syringe drawn from the 10 mg + 10 mg vial. Standard protocols deliver this dose once daily before bed, which aligns the GH pulse with the body's natural overnight GH release window. Some providers split the dose morning and evening for older patients with disrupted sleep. Your provider sets the protocol per your goals and lab work.

When should I take CJC-1295/Ipamorelin?

The most common timing is 30 minutes before bed on an empty stomach. Food in the stomach (especially carbohydrates) blunts the GH pulse, so most providers recommend nothing to eat for 2 hours before the injection. Taking it before bed leverages the natural overnight GH peak that occurs during slow-wave sleep. A morning dose (also fasted) is acceptable if before-bed timing is not practical.

Where do I inject CJC-1295/Ipamorelin?

Inject subcutaneously into the abdomen, upper outer thigh, or back of the upper arm. Rotate sites between injections. Use a 31-gauge, 5/16-inch (8 mm) needle on a U-100 insulin syringe. CJC-1295/Ipamorelin ships pre-reconstituted from Optimal Balance Pharmacy and is ready to inject; store refrigerated after first puncture per the in-use BUD on your label.

Does CJC-1295/Ipamorelin increase testosterone?

CJC-1295/Ipamorelin does not directly increase testosterone. The peptides act on growth hormone-releasing pathways at the pituitary, not on testicular Leydig cells or the HPG axis. Some users report improvements in energy and libido, which are typically attributed to indirect effects of better sleep and improved body composition rather than an actual T increase. If testosterone optimization is your goal, ask your provider about TRT options separately.

Is CJC-1295/Ipamorelin a steroid?

No. CJC-1295 and Ipamorelin are peptides, not steroids. They do not contain a steroid backbone, do not bind to androgen receptors, and do not suppress the HPG axis the way exogenous testosterone or anabolic steroids do. The peptides stimulate the body's own growth hormone production through receptor binding at the pituitary; growth hormone is also not a steroid. WADA classifies GH secretagogues separately from anabolic-androgenic steroids.